These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of myelin-specific gene expression. Relevance to CMT1. Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235 [TBL] [Abstract][Full Text] [Related]
3. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study. Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245 [TBL] [Abstract][Full Text] [Related]
4. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170 [TBL] [Abstract][Full Text] [Related]
5. TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Sahenk Z; Galloway G; Edwards C; Malik V; Kaspar BK; Eagle A; Yetter B; Forgie A; Tsao D; Lin JC Exp Neurol; 2010 Aug; 224(2):495-506. PubMed ID: 20553714 [TBL] [Abstract][Full Text] [Related]
6. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Naef R; Adlkofer K; Lescher B; Suter U Mol Cell Neurosci; 1997 Jan; 9(1):13-25. PubMed ID: 9204477 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture. Liu N; Varma S; Shooter EM; Tolwani RJ J Neurosci Res; 2005 Feb; 79(3):310-7. PubMed ID: 15605381 [TBL] [Abstract][Full Text] [Related]
8. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Tobler AR; Liu N; Mueller L; Shooter EM Proc Natl Acad Sci U S A; 2002 Jan; 99(1):483-8. PubMed ID: 11752407 [TBL] [Abstract][Full Text] [Related]
9. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity. Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544 [TBL] [Abstract][Full Text] [Related]
10. Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy. Rosso G; Negreira C; Sotelo JR; Kun A J Mol Recognit; 2012 May; 25(5):247-55. PubMed ID: 22528185 [TBL] [Abstract][Full Text] [Related]
11. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells. Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616 [TBL] [Abstract][Full Text] [Related]
12. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015 [TBL] [Abstract][Full Text] [Related]
13. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Dickson KM; Bergeron JJ; Shames I; Colby J; Nguyen DT; Chevet E; Thomas DY; Snipes GJ Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9852-7. PubMed ID: 12119418 [TBL] [Abstract][Full Text] [Related]
14. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation. Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691 [TBL] [Abstract][Full Text] [Related]
15. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Maier M; Berger P; Nave KA; Suter U Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842 [TBL] [Abstract][Full Text] [Related]
16. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Naef R; Suter U Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969 [TBL] [Abstract][Full Text] [Related]
17. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283 [TBL] [Abstract][Full Text] [Related]
18. Trembler as a mouse model of CMT1A? Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251 [TBL] [Abstract][Full Text] [Related]
19. Pmp22 mutant allele-specific siRNA alleviates demyelinating neuropathic phenotype in vivo. Lee JS; Chang EH; Koo OJ; Jwa DH; Mo WM; Kwak G; Moon HW; Park HT; Hong YB; Choi BO Neurobiol Dis; 2017 Apr; 100():99-107. PubMed ID: 28108290 [TBL] [Abstract][Full Text] [Related]
20. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies. Zielasek J; Toyka KV Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]